3.
Factor | n (%) | MST (month) | 95%CI (month) | P | |
Total | 45 | 24 | 18.0-30.0 | ||
Sex | Male | 35 (77.8) | 24 | 18.5-29.5 | 0.897 |
Female | 10 (22.2) | 16 | 13.1-18.9 | ||
Age (yr) | 65-75 | 37 (82.2) | 24 | 14.1-33.9 | 0.096 |
≥75 | 8 (17.8) | 13 | 6.3-19.7 | ||
PS before treatment (ECOG) | 0 | 10 (22.2) | 33 | 15.5-50.5 | 0.045 |
1 | 32 (71.1) | 20 | 11.9-28.1 | ||
2 | 3 (6.7) | 12 | 0-28 | ||
3 | 0 (0) | NR | NR | ||
The change of PS after treatment | Improve | 15 (33.3) | 24 | 14.6-33.4 | 0.553 |
Stable | 26 (57.8) | 18 | 8.2-27.8 | ||
Worsen | 4 (8.9) | 20 | 13.6-26.4 | ||
Chemotherapy scheme | EP or EC | 32 (71.1) | 24 | 16.2-31.8 | 0.855 |
Not EP or EC | 13 (28.9) | 17 | 7.8-26.2 | ||
Radiotherapy | Yes | 29 (64.4) | 26 | 17.8-34.2 | 0.026 |
No | 16 (35.6) | 18 | 7.2-28.8 | ||
Radiotherapy pattern | Concurrent | 17 (58.6) | 27 | 18.9-35.1 | 0.813 |
Sequential | 12 (41.4) | 24 | 7.1-40.9 | ||
Radiotherapy time | Early | 7 (41.2) | 27 | 19.3-34.7 | 0.270 |
Late | 10 (58.8) | 26 | 1.2-50.8 | ||
PCI | Yes | 16 (44.4) | 29 | 24.0-34.0 | 0.288 |
No | 20 (55.6) | 23 | 16.0-30.0 |